Survival Prediction for Terminally Ill Cancer Patients: Revision of the Palliative Prognostic Score with Incorporation of Delirium

Author:

Scarpi Emanuela1,Maltoni Marco2,Miceli Rosalba3,Mariani Luigi3,Caraceni Augusto4,Amadori Dino5,Nanni Oriana1

Affiliation:

1. a Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy

2. b Palliative Care Clinic, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy

3. c Unit of Clinical Epidemiology and Trial Organization, National Cancer Institute, Milan, Italy

4. d Palliative Care Unit (Pain Therapy-Rehabilitation), National Cancer Institute, Milan, Italy

5. e Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy;

Abstract

Abstract Learning Objectives After completing this course, the reader will be able to: Describe the effect on the palliative prognostic score classifications when delirium was included as a variable.Compare changes in overall survival times when delirium was added to the palliative prognostic score. CME This article is available for continuing medical education credit at CME.TheOncologist.com Purpose. An existing and validated palliative prognostic (PaP) score predicts survival in terminally ill cancer patients based on dyspnea, anorexia, Karnofsky performance status score, clinical prediction of survival, total WBC, and lymphocyte percentage. The PaP score assigns patients to three different risk groups according to a 30-day survival probability—group A, >70%; group B, 30%–70%; group C, <30%. The impact of delirium is known but was not incorporated into the PaP score. Materials and Methods. Our aim was to incorporate information on delirium into the PaP score based on a retrospective series of 361 terminally ill cancer patients. We followed the approach of “validation by calibration,” proposed by van Houwelingen and later adapted by Miceli for achieving score revision with inclusion of a new variable. The discriminating performance of the scores was estimated using the K statistic. Results. The prognostic contribution of delirium was confirmed as statistically significant (p < .001) and the variable was accordingly incorporated into the PaP score (D-PaP score). Following this revision, 30-day survival estimates in groups A, B, and C were 83%, 50%, and 9% for the D-PaP score and 87%, 51%, and 16% for the PaP score, respectively. The overall performance of the D-PaP score was better than that of the PaP score. Conclusion. The revision of the PaP score was carried out by modifying the cutoff values used for prognostic grouping without, however, affecting the partial scores of the original tool. The performance of the D-PaP score was better than that of the PaP score and its key feature of simplicity was maintained.

Funder

Istituto Oncologico Romagnolo

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference35 articles.

1. Trends in the aggressiveness of cancer care near the end of life;Earle;J Clin Oncol,2004

2. Predicting survival in patients with advanced disease;Glare;Eur J Cancer,2008

3. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review;Chow;Clin Oncol (R Coll Radiol),2001

4. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer;Vigano;Cancer,1999

5. A new palliative prognostic score: A first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care;Pirovano;J Pain Symptom Manage,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3